secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zivo Bioscience, Inc. (ZIVO)
CIK:        0001101026
Form:       8-K/A
Filed at:   2022-03-01T23:59:59+00:00
Accession:  0001654954-22-002336
Event type: leadership
Sentiment:  negative
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Zivo reaffirms former CEO Andrew Dahl was terminated for cause, disputes his email claims
--------------------------------------------------------------------------------

- Company states Board terminated Andrew Dahl for cause; he was offered chance to resign before termination.
- Dahl's email (Exhibit 17) challenged company's account; Company maintains its initial filing was accurate.
- Company confirms it filed original 8-K and this amendment within SEC-prescribed timelines.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1101026/000165495422002336/0001654954-22-002336-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1101026/000165495422002336/zivo_8ka.htm
  HTML page:      https://secwatch.observer/filing/0001654954-22-002336

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer